SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 258 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,488,000 | -91.1% | 50,280 | -96.2% | 0.23% | -90.3% |
| Q4 2017 | $72,886,000 | +11.8% | 1,309,960 | -8.9% | 2.37% | +8.6% |
| Q3 2017 | $65,218,000 | -4.8% | 1,437,770 | -29.2% | 2.18% | -11.6% |
| Q2 2017 | $68,495,000 | +49.3% | 2,031,890 | +31.1% | 2.47% | +17.4% |
| Q1 2017 | $45,880,000 | +313.1% | 1,550,000 | +324.7% | 2.10% | +276.6% |
| Q2 2015 | $11,107,000 | +80.7% | 365,000 | -21.1% | 0.56% | +90.8% |
| Q1 2015 | $6,145,000 | -62.8% | 462,700 | +32.2% | 0.29% | -66.9% |
| Q3 2013 | $16,530,000 | – | 350,000 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |